Back to Journals » OncoTargets and Therapy » Volume 6

Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities

Total article views   Abstract views HTML views PDF downloads Totals
9,009 Dovepress* 6,263 508+ 1,587 6,771
PubMed Central* 12 2,226 1,150 2,238
Totals 6,275 2,734 2,737 9,009
*Since 24 July 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar